(Q37100337)

18 August 2017

A phase II dose-ranging study of mirabegron in patients with overactive bladder (English)

1 reference

18 August 2017

0 references

Christopher R Chapple

object named as

Christopher R Chapple

1

0 references

Jean-Jacques Wyndaele

5

object named as

Jean Jacques Wyndaele

1 reference

18 August 2017

Vladimir Dvorak

2

1 reference

18 August 2017

Pjotr Radziszewski

3

1 reference

18 August 2017

Philip Van Kerrebroeck

4

1 reference

18 August 2017

Brigitte Bosman

6

1 reference

18 August 2017

Peter Boerrigter

7

1 reference

18 August 2017

Ted Drogendijk

8

1 reference

18 August 2017

Arwin Ridder

9

1 reference

18 August 2017

Ingrid Van Der Putten-Slob

10

1 reference

18 August 2017

Osamu Yamaguchi

11

1 reference

18 August 2017

Dragon Investigator Group

12

1 reference

18 August 2017

8 March 2013

1 reference

International Urogynecology Journal and Pelvic Floor Dysfunction

18 August 2017

1 reference

18 August 2017

24

1 reference

18 August 2017

9

1 reference

18 August 2017

1447-1458

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

18 August 2017

start time

8 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00192-013-2042-x

0 references

cites work

Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Recent developments in the management of detrusor overactivity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3745617

Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods

20 October 2018

1 reference

12 December 2020

Expression and possible functional role of the beta3-adrenoceptor in human and rat detrusor muscle

1 reference

12 December 2020

Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin

1 reference

12 December 2020

The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS

1 reference

12 December 2020

Patient-reported reasons for discontinuing overactive bladder medication

1 reference

12 December 2020

10.1007/S00192-013-2042-X

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference